Factors that effect sputum culture convertion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy

Tuberkuloz ve Toraks

Volumn 58, Issue 1, 2010, Pages 44-52

  Uzundaǧ Işeri, Ayşe ^a   Dulkar, Güngör ^b   Selçuk Sönmez, Özlem ^b   Yilmaz Aydin, Leyla ^b   Yilmaz, Birsen ^c  

^a Pediatric Surgery Division   (Turkey)

^b Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^c Isparta City Department of Turkish Ministry of Health   (Turkey)

Author keywords

DOTS; Drug resistance tuberculosis; Sputum culture convertion; Treatment results; Tuberculosis treatment

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLACEAE; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DIRECTLY OBSERVED THERAPY; FEMALE; GENDER; HEMOPTYSIS; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NIGHT SWEAT; RISK FACTOR; SMOKING; SPUTUM CULTURE; ADOLESCENT; MICROBIOLOGY; MIDDLE AGED; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77951695044     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686
2. Özkara Ş, Aktaş Z, Özkan S, Ecevit H. Türkiye'de Tüberkülozun Kontrolü için Başvuru Kitabi. Ankara: Ofset Basimevi, 2003: 7-52.
3. Sonnenwirth AC, Jarrett L. Cradwohl's clinical laboratory methods and diagnosis. 1699-1703
4. Liu Z, Kennet LS, Herman ME. Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med 1999; 159: 1110-1116 (Pubitemid 29230864)
5. Schon T, Elias D, Moges F, et al. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J 2003; 21: 483-488 (Pubitemid 36336209)
6. Telzak EE, Fazal BA, Pollard CL, et al. Factors influencing time to sputum conversion among patients with smearpositive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-670 (Pubitemid 127774281)
7. Lienhardt C, Manneh K, Bauchier V, et al. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718 (Pubitemid 28429720)
8. Özkara Ş, Arpaz S, Özkan S ve ark. Tüberküloz tedavisinde doǧrudan gözetimli tedavi (DGT). Solunum Hastaliklari 2003; 14: 150-157
9. Özkara Ş, Kiliçarslan Z, Öztürk F ve ark. Bölge verileriyle Türkiye'de tüberküloz. Toraks Dergisi 2002; 3: 178-187
10. Feng-Zeng Z, Murray C, Spinaci S. Result of directly observed short-course chemotherapy in 112842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358-362 (Pubitemid 26046103)
11. Wilkinson D, Davies GR, Connolly C. Directly observed therapy for tuberculosis Rural South Africa, 1991 through 1994. Am J Public Health 1996; 86: 1094-1097
12. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relaps in tuberculosis. N Engl J Med 1994; 330: 1179-1184
13. Global Tuberculosis Control Surveillance, Planning, Financing. WHO 2006 Geneva, World Health Organization (WHO/HTM/TB/2006. 362).
14. Chaulk CP, Moore-Rice K, Rizzo R. Eleven years of community- based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951
15. Arpaz S, Keskin S, Sezgin N ve ark. Nazilli Verem Savaş Dispanseri DOTS deneyimleri sonuçlari. Toraks Dergisi 2001; 2 (Ek 1): 40 (özet, SS.151).
16. Kolsuz M, Ersoy M, Küçükkebabci C ve ark. Akciǧer tüberkülozu olgularinda balgam tetkiklerinin sonuçlari ve bunlari etkileyen faktörler. Solunum Hastaliklari 2003; 14: 193-199
17. Pungrassami P, Chongsuvivatwong V, Olsen J. Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand? Trop Med Int Health 2002; 7: 271-279
18. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-966
19. Emri S. Sigara ve saǧlik. Bariş YI (editör). Solunum Hastaliklari Temel Yaklaşim. Ankara: Kent Matbaasi, 1995: 471-479
20. Ataç G, Sevim T, Güngör G ve ark. Akciǧer tüberkülozlu olgularda yayma ve kültür negatifleşme süresini etkileyen faktörler. Toraks Dergisi 2001; 2: 16-20.